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Sea turtle fibropapillomatosis (FP) is a tumor promoting disease that is one of several
threats globally to endangered sea turtle populations. The prevalence of FP is highest in
green sea turtle (Chelonia mydas) populations, and historically has shown considerable
temporal growth. FP tumors can significantly affect the ability of turtles to forage for
food and avoid predation and can grow to debilitating sizes. In the current study, based
in South Texas, we have applied transcriptome sequencing to FP tumors and healthy
control tissue to study the gene expression profiles of FP. By identifying differentially
expressed turtle genes in FP, and matching these genes to their closest human ortholog
we draw on the wealth of human based knowledge, specifically human cancer, to
identify new insights into the biology of sea turtle FP. We show that several genes
aberrantly expressed in FP tumors have known tumor promoting biology in humans,
including CTHRC1 and NLRC5, and provide support that disruption of the Wnt signaling
pathway is a feature of FP. Further, we profiled the expression of current targets of
immune checkpoint inhibitors from human oncology in FP tumors and identified potential
candidates for future studies.
Keywords: fibropapillomatosis, RNA-seq, chelonid alphaherpesvirus 5 (ChHV5), precision wildlife medicine,
conservation medicine, Chelonia mydas, cancer
INTRODUCTION
Sea turtle fibropapillomatosis (FP) is a tumor promoting disease that occurs globally in all seven
species of sea turtles. The species known for having the highest FP prevalence is the green sea turtle
(Chelonia mydas) (1). FP was first reported over 80 years ago in captured green turtles from the
Florida Keys, USA (2). Despite sustained and/or increased detection in Florida (3, 4), Hawaii (5–
7), and other areas globally (8, 9), FP was not detected in Texas, USA until 2010 (10). Since then
the prevalence of this disease in Texas has increased dramatically. From 2010 to 2015 the yearly
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prevalence of FP in Texas among stranded turtles was a
maximum of 5% each year (11). After 2015, the prevalence of
FP in Texas grew substantially to over 35% in green turtles in
2018 (11).
The most visibly prominent feature of FP is the appearance of
external cutaneous tumors on affected turtles (Figure 1) (12–15).
Ocular, oral and internal tumors are also a disease component,
affecting the visceral organs including the lungs, kidneys, and
also bone (16). Juvenile sea turtles are recognized as the most
affected age category, but FP has also been reported in adult
nesting olive ridley turtles (Lepidochelys olivacea) in Costa Rica
(17) indicating that this disease is not limited to a life stage.
Tumors may spontaneously regress, or increase in size and/or
number to the point of debilitation (18). The primary impact of
FP is the decrease in ability of sea turtles to forage for food, swim,
and avoid predation, thus affecting the overall survival of affected
turtles (16). Clinical pathology profiles of FP affected turtles have
also identified systemic effects of the disease including anemia,
particularly among the most severely affected turtles (19–22).
As green turtles are recognized by the International Union for
the Conservation of Nature and Natural Resources as threatened
with extinction (23) health problems like FP that affect remaining
populations are of major concern to conservation efforts.
The primary cause of FP is unknown. Several lines of
evidence point to a herpesvirus [chelonid alphaherpesvirus 5
(ChHV5)] as a potential causal agent of FP (4, 24–27), which is
reminiscent of human cancers with known viral origins including
FIGURE 1 | Two fibropapillomatosis affected juvenile green turtles (Chelonia
mydas) undergoing rehabilitation at Sea Turtle Inc., South Padre Island, Texas,
USA. Turtle 1 (A,B) and turtle 2 (C,D) both display prominent external tumors
on their ventral side (A,C) and also ocular tumors (B,D).
Epstein-Barr virus infection in Burkitt’s lymphoma (28), human
herpesvirus-8 infection in Kaposi sarcoma (29), and human
papillomavirus infection in cervical cancer (30). There is a strong
suggestion that it is ChHV5 together with other environmental
and anthropogenic pressures that has contributed to the growth
of FP prevalence [reviewed in (1)].
For sea turtles debilitated by FP that are admitted to
rehabilitation facilities for treatment, the current standard of care
is preoperative screening for internal tumors, which carry poor
prognosis, followed by surgical excision of external tumors (31).
A recent report from (15) shows that postoperative regrowth
is seen in 50% of treated turtles and that the rehabilitation
survival rate of FP affected turtles is low (25%). Given the
significant advancements in human precision oncology and the
potential applications in wildlife medicine (32–34) it seems
reasonable to expect increasing the understanding of the
biological features of FP may result in additional therapeutic
approaches to the treatment of this disease. In turn this may
increase survival rates, reduce tumor reoccurrence and minimize
rehabilitation time. Moreover, insight into pathogenesis of tumor
development may inform hypotheses related to disease etiology
and expression.
In 2018, Duffy et al. (35) reported the first application
of human precision oncology techniques to FP. The study
undertook a molecular characterization of FP tumors in two
juvenile green turtles from Florida, performing RNA-sequencing
of seven tumor samples and three matched skin control samples.
This was the first effort to characterize the genetic disruptions
in FP and was a significant advancement in the molecular
understanding of this disease. More recent work from this group
has explored the shared and distinct genomic and transcriptomic
profiles of internal and external FP tumors (36).
Here, we continue the efforts to understand the genetic
perturbations of FP tumors through transcriptome sequencing of
healthy and tumor tissue from stranded green turtles undergoing
rehabilitation at Sea Turtle Inc., on South Padre Island, Texas,
USA. We aimed to study FP in a geographically distinct
population of green turtles, hypothesizing that both similarities
and differences will emerge between the transcriptomic profiles
of FP tumors in Texas and Florida. By drawing upon the wealth
of biological knowledge established in humans, this study aimed
to further characterize FP to understand the biological pathways
disrupted in this disease and to identify potential therapeutic
avenues for future investigation.
RESULTS
Patient Characteristics
During 2017–2018, 35 tissue samples were collected from nine
green turtles undergoing rehabilitation at Sea Turtle Inc., after
stranding at South Padre Island, Texas. As summarized in
Table 1, 26 FP tumors and three healthy tissue biopsies were
collected from three turtles with FP. Healthy tissue biopsies were
also obtained from six turtles with no visible evidence of FP.
The most common cause of stranding among the sampled
sea turtles was cold stunning (4/9 turtles). The remaining
turtles stranded due to trauma from injury (2/9), fishing hook
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TABLE 1 | Characteristics of juvenile green sea turtles, stranded at South Padre Island, Texas.
ID Turtle FP Stranding
date
















FP01 Reveille Yes 01/30/18 Head injury and eye injury 29.4 6.05 3.5 1 5 3 (3) 1+
FP02 Frostbite Yes 01/23/18 Cold stun 40.9 9.95 3 1 3 4 (4) 1+
FP03 Beach Bum Yes 01/30/18 Lethargic in tide line 41.7 8.6 2 2 2 19 (13) 1+
FP07 Robocop No 01/02/18 Cold stun 55.7 20.6 2.5 NA NA NA 1−
FP08 Rocko No 04/02/18 Hooked 35.6 6.1 3 NA NA NA 1?
FP09 Gobbler No 11/23/17 Boat strike 32.2 6.2 1.5 NA NA NA 1+
FP10 Captain Cloud No 03/26/18 Hooked 30.1 3.25 3 NA NA NA 1−
FP11 Sapphire No 02/08/18 Cold stun 27.4 3.1 3 NA NA NA 1+
FP12 Gilligan No 01/16/18 Cold stun 27.6 3.5 4 NA NA NA 1−
aStraight carapace length, notch to tip. bSubjective body condition score is measured on a 1–5 scale, where 1 is considered extremely emaciated and 5 is considered obese. cThe
number in brackets indicates the number of tumors in this turtle that ChHV5 transcripts were detected in the RNA-seq data, note that one sample for FP03 was not measured. dHealthy
tissue samples where ChHV5 transcripts were detected are indicated with a + notation, − when none is detected and ? when not measured.
FIGURE 2 | Principal components analysis of gene expression in healthy
(green) and tumor (orange) samples, incorporating 2 factors of unwanted
variation calculated using RUVSeq. PC 1 separates healthy from tumor
samples and explains 24.62% of the variation in gene expression
across samples.
ingestion/entanglement (2/9), and lethargy (1/9). All turtles were
juveniles with straight carapace lengths (nuchal notch to caudal
extent of the carapace) and weight ranging from 27.4 to 55.7 cm
(µ = 35.6 cm) and 3.1–20.6 kg (µ = 7.5 kg), respectively. For
the three turtles that had FP tumors at collection, using the
NOAA tumor burden scale of 1–3 (where 1 is least affected
and 3 is most affected), two turtles were classified as category
1 and one turtle was category 2 (37). All FP affected turtles
underwent multiple tumor excisions by CO2 laser, with turtle
FP03 requiring two surgeries due to tumor load. Turtles FP01
underwent five surgeries and FP02 three surgeries each requiring
multiple surgeries due to tumor regrowth. All turtles were
rehabilitated successfully at Sea Turtle Inc., and released.
General features observed from histopathology profiling
of tumors collected and sequenced in this study confirmed
samples as FP and identified common concurrent features
including mild to moderate lymphocytic infiltration in all
tumors, ulceration in tumor FP01–02 and secondary bacterial
infection in tumor FP02–05.
Differential Gene Expression Analysis of
Healthy vs. Tumor Tissue
Our analysis of gene expression compared eight healthy control
skin samples to 25 tumor samples across eight turtles total.
Two samples, both tumors, from the originally sequenced 35
were excluded during quality control. Of the 21,432 transcripts
annotated in the CheMyd 1.0 reference genome, 17,698 (82.6%)
had sufficiently large enough counts in this sample set to be
retained for statistical analysis. Using DESeq2, the design of
this analysis controlled for two factors of unwanted variation
calculated with RUVseq as well as the individual turtle (to
account for differences in the number of tumor samples obtained
from each FP turtle). As expected, principal components analysis
of global gene expression profiles for each sample clustered
distinctly healthy control skin samples separately from FP tumors
(Figure 2), separating the two sample types in the first principal
component which explained 24.62% of sample variation.
For differential gene expression analysis, a log fold change
threshold of 1 and an alpha of 0.05 were chosen. This
analysis identified 283 transcripts that were upregulated, and
90 transcripts that were downregulated (Figure 3). The 10
most significantly upregulated, and 10 most significantly
downregulated genes are shown in Figure 4 and described in
Table 2. All gene expression differences are summarized in
Supplementary Table 1.
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FIGURE 3 | Volcano plot of differentially expressed genes in FP tumor samples compared to healthy control skin. The x-axis plots the log2 fold change from healthy
control skin to tumor samples, while the y-axis plots the –log10 adjusted P-value resulting from the differential expression analysis.
Functional Enrichment and Pathway-Based
Analysis of Differentially Expressed Genes
To extend beyond individual differentially expressed genes and
to examine the broader biological processes involved in FP
tissue, turtle genes were mapped to their closest human gene
ortholog. This then enabled analyses that draw upon well-
characterized biological networks from human-based data to
infer understandings in sea turtle FP.
Among the 17,698 sea turtle genes that underwent differential
expression analysis between healthy tissue and tumors, 91.2%
were successfully matched to a human ortholog through BLAST-
based analysis. For the 373 significantly differentially expressed
genes, 327 (87.7%) were matched to 302 human orthologs.
GSEA using GO terms and KEGG pathways was conducted
using clusterProfiler. For this analysis we relaxed the significance
threshold and considered genes with an adjusted p < 0.1 as
input on the basis that biologically relevant expression changes
may be reflected in this expanded list. This increased the
number of genes to 459 of which 407 (88.7%) were matched
to 374 human orthologs. For each duplicate ortholog the
most significant differentially expressed gene value was used in
downstream analyses.
From the GO based analysis, 465 nominally significant (p <
0.05) terms were identified as enriched within the 374 genes
(Supplementary Table 2). The top ranked terms were primarily
immune system related. The top 20 most significant GO
biological process ontology terms are shown in Figure 5. When
the genes overlapping between these GO terms are considered as
an enrichment map (Figure 6), two functional modules emerge.
One module specifically involves biological processes related to
responses to bacteria and interferon-gamma and the second
module is related to immune cells and immune processes.
From the KEGG pathway based analysis, 32
nominally significant pathways, shown in Figure 7
(Supplementary Table 3), were identified as over-represented
within the differentially expressed genes. The most significantly
enriched pathway was hsa04060, cytokine-cytokine receptor
interaction, adjusted p = 8.72 × 10−7. Again, considering
an enrichment map (Figure 8) between these pathways it is
clear that immunological processes are driving the differential
expression of genes between FP tumors and normal tissue.
Targeted Analysis of Immune Checkpoint
Dysregulation in FP Tumors
Inhibition of immune checkpoint molecules, including
CTLA4 and PD1, are current therapeutic targets in human
precision oncology. Given their high therapeutic potential, we
specifically assessed the gene expression of immune checkpoint
molecule orthologs in this data including both established and
emerging targets, as reviewed in (38, 39) and summarized in
Supplementary Table 4. Of the 13 molecules targeted from
the literature, 12 were present as orthologs in the sea turtle
transcriptome based on protein sequence homology, with PD-
L1, B7–H3, and CTLA-4 matching multiple sea turtle proteins.
TIGIT was not detected. Three immune checkpoint molecules,
BTLA, PD-L2, and LAG3, were significantly upregulated in FP
tumors (Figure 9, Table 3). The most significant being PD-L2
(LOC102933512), with a log2fold increase of 3.27, padj = 0.0001.
Similarities and Differences Between Gene
Expression Profiles of FP From Sea Turtles
in Texas and Florida
Previously in the first reported transcriptomic profiling of FP,
Duffy et al. sequenced 3 healthy control samples and 7 tumor
samples from 2 green turtles in Florida (35), assembled a de
novo transcriptome and conducted a differential gene expression
analysis. Here we compare our findings where possible with
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FIGURE 4 | The top 10 upregulated (upper panels) and downregulated (lower panels) differentially expressed genes in FP tumors. The x-axis in each plot panel
separates the box plots of tissue samples into the healthy control skin group and tumor group. The y-axis plots the log2-transformed normalized read count for each
sample.
these earlier findings. Duffy et al. reported the top 10 up-
regulated and top 10 down-regulated transcripts in their analysis
of which 12 were annotated to a matching human ortholog.
Supplementary Table 5 compares the differential expression
results for these 12 genes between the Duffy et al. (35) turtles
from Florida and the turtles in this current study. Of the 12
genes, only four (FNDC1, S1PR3, NES, NTN3) were statistically
replicated in this study, however all showed the same direction of
expression change.
Recognizing that the results from the two sample cohorts are
derived from different sequencing and analytical pipelines we can
compare the trend in overall log2fold changes in gene expression
where possible. Duffy et al. report their top 300 up-regulated
and top 300 down-regulated transcripts. Where a human gene
annotation was assigned to a transcript, we have correspondingly
matched that gene to our data, allowing for multiple matches
where the same gene symbol is assigned to multiple transcripts.
Figure 10A shows the direct comparison of log2fold changes
in gene expression between 449 overlapping observations from
Duffy et al. and this study. Two transcripts from the Duffy study,
both corresponding to the TBX20 gene were excluded as outliers
as the TBX20 gene had a log2fold change of 21.8 in our study,
in comparison to 2.9 and 3.6 in the Duffy study. The overlap
between studies was highly correlated (R = 0.76, p < 2.2 ×
10−16), with a decrease in correlation to R = 0.68 with inclusion
of TBX20 data points. This high correlation was increased when
considering only the subset of transcripts (N = 98) that were
significantly differentially expressed in both studies (R = 0.86, p
< 2.2× 10−16) as seen in Figure 10B.
Detection of ChHV5 Transcript Expression
in Both Tumor and Normal Tissue
We aligned the RNA sequence data from this study to the
ChHV5 reference genome to identify sample level evidence of the
presence of the ChHV5 virus. Of the 104 defined gene features
in the ChHV5 genome, 83 were detected in this sample set.
Total alignment counts across all 83 transcripts ranged from 0
to 483,216, with <10 counts in the majority of samples (22/33).
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LOC102930327 MR1 2.92 0.17 1.22 × 10−25
CTHRC1 CTHRC1 6.60 0.53 6.06 × 10−22
TBX20 TBX20 21.75 2.15 2.63 × 10−18
LOC114021482 RNF213 3.47 0.26 1.69 × 10−17
LOC102948206 N/A 16.86 1.89 1.29 × 10−13
NLRC5 NLRC5 3.39 0.30 3.71 × 10−12
LOC114018352 UBB 4.26 0.42 8.19 × 10−12
CD4 CD4 4.49 0.46 3.68 × 10−11
LOC102931356 CASP8 3.50 0.33 9.16 × 10−11
TMSB4X TMSB4X 2.42 0.20 1.03 × 10−9
Downregulated
TBX4 TBX4 −7.35 0.71 1.00 × 10−15
CCER2 CCER2 −7.76 0.87 1.99 × 10−11
LOC114020549 BTAF1 −5.63 0.64 7.41 × 10−10
LGR5 LGR5 −4.56 0.50 1.03 × 10−9
LOC114020545 PLIN2 −2.27 0.22 8.27 × 10−6
LOC114021518 N/A −4.11 0.56 1.08 × 10−5
LOC114021212 N/A −4.21 0.58 1.13 × 10−5
ENPP6 ENPP6 −3.91 0.53 1.66 × 10−5
LOC102936807 KRT73 −9.18 1.54 3.58 × 10−5
LOC114019042 N/A −5.98 0.94 3.60 × 10−5
Across the eight healthy tissue samples RNA molecules aligning
to ChHV5 virus transcripts were detected in five, including all
three healthy tissue samples from the FP affected turtles. In tumor
samples alignment to virus transcripts was detected in 20/25
samples with two tumors from the same turtle (FP01) exhibiting
high levels of RNA molecules aligning to ChHV5 transcripts.
Five tumors, all from turtle FP03 had no evidence of ChHV5
transcript expression. The number of tumors in each turtle and
healthy tissue in which ChHV5 transcripts were detected are
indicated in Table 1. We report with interest that the two tumors
from turtle FP01 with the apparent highest virus levels exhibited a
smooth, raised surface with altered pigmentation in comparison
to surrounding normal tissue, in comparison to the more typical
verrucous character of the other tumors in this study.
DISCUSSION
The prevalence of FP in Texas is growing among juvenile
green turtles inhabiting nearshore habitat. As a wildlife health
problem threatening an endangered species there is considerable
need for further biological insight into this disease. Here, we
have conducted transcriptome sequencing to identify differential
gene expression profiles between healthy skin samples and FP
tumors. Our analysis has identified 373 significantly differentially
expressed sea turtle transcripts between healthy and tumor tissue.
Through protein sequence homology analysis, we identified,
where possible, the best matching human ortholog for each
transcript. This facilitated exploration of both known biology
at the gene level, but also allowed GSEA to identify aberrantly
affected biological processes and pathways.
At the gene level, among the most significantly up-regulated
and down-regulated genes resulting from this analysis are several
genes currently implicated as important in human oncology.
Expression of LOC102930327 which was found to be orthologous
with human MR1 (major histocompatibility complex, class I-
related) is upregulated in sea turtle FP tumors (log2FoldChange
= 2.92, padj = 1.22 × 10
−25). MR1 has a known role in
the innate immune system as a selector and/or restrictor of
mucosal-associated invariant T (MAIT) cells, which have a role
in microbial defense (40–42). Through antigen presentation by
MR1, MAIT lymphocytes are activated by microbially-derived
intermediates of riboflavin synthesis (43). MAIT cells are the
dominant lymphocyte population in human skin and also have
a role in promoting tissue repair and wound healing (44).
As FP tumors have been observed to have bacterial infections
previously (5) as well as in the current study, we posit that the
identified MR1 upregulation in FP tumors is an antimicrobial
response and while not directly related to FP tumorgenicity
may contribute to a permissive tumor microenvironment
through inflammation upregulation. It is possible that as FP
tumors develop and tissue becomes compromised, facilitating
bacterial infection, the infection in turn contributes to continued
tumor growth.
Expression ofCTHRC1 (collagen triple helix repeat containing
1) is also upregulated in FP tumors (log2FoldChange = 6.60,
padj = 6.06 × 10
−22). In humans, CTHRC1 encodes an
extracellular matrix protein that was originally identified from
an upregulation in models of arterial injury (45). Further
research has led to the recognition of CTHRC1 as an oncogenic
protein with a role in the promotion of tumor growth, invasion
and metastasis in multiple malignancies. CTHRC1 expression
is increased in hepatocellular carcinoma (46, 47), melanoma
(48) and breast cancer (49) and in several studies increased
mRNA and protein expression in tumors was associated with
poor disease prognosis and survival (46, 49–52). Further,
increased CTHRC1 has been linked to the upregulation of
matrix metalloproteinases (MMPs) which have established roles
in tumor progression and metastasis in humans (53). In
hepatoma cells (54), and colorectal cancer cells (50) increased
CTHRC1 activated expression of MMP-9, which is known
to contribute to extracellular matrix breakdown and tumor
promotion (53). Increased expression of MMP9 was associated
with poorer outcomes in nasopharyngeal carcinoma patients (55)
and together with increased expression of CTHCR1 and MMP7,
higher expression ofMMP9 was associated with a lower survival
rate after surgery in non-small cell lung cancer patients (56).
This known connection between CTHCR1 and MMP7/MMP9
is reflected in the current study, with significant upregulation
of CTHRC1 in FP tumors accompanied by increased expression
of MMP7 (log2FoldChange = 4.26, padj = 8.87 × 10
−9)
and MMP9 (log2FoldChange = 4.24, padj = 4.05 × 10
−8;
Supplementary Table 1). Together this suggests that CTHRC1
may be a key oncogenic driver in FP.
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FIGURE 5 | A dot plot of the top 20 most significant GO biological process ontology terms enriched among differentially expressed genes in FP. The x-axis shows the
ratio of differentially expressed genes in each term relative to the total number of genes in that term. Dot size shows the number of differentially expressed genes in
that term and color is the gene set enrichment analysis test statistic with Benjamini–Hochberg adjustment for multiple testing.
The most significantly downregulated gene expressed in FP
tumors was TBX4 (log2FoldChange = −7.35, padj = 1.00 ×
10−15). Encoding T-box transcription factor 4, TBX4, belongs to
a highly evolutionarily conserved family of transcription factors
responsible for limb development with fundamental roles during
embryogenesis (57, 58). Given that Tbx4 expression in chick
embryos determines hind limb development (59, 60), and that the
healthy control tissue samples used in the current project were
obtained from punch biopsies of the hind flippers, it is possible
that the higher expression of TBX4 in healthy tissue in this study
is due to tissue source. This finding warrants further investigation
through gene expression comparisons of hind flipper tissue with
non-hind flipper healthy skin. Indeed a limitation of this study is
that control tissue was only sourced from hind flipper biopsies
as collection from other external healthy epidermal tissue was
not pursued to minimize impact to study turtles. The sustained
expression of a gene known as an embryonic transcription factor
in adult tissue initially seems counterintuitive. However, TBX4
has been implicated as a transcription factor of importance
in human adult lung fibroblasts (61). Furthermore, TBX4 has
been shown to have decreased expression in human lung
cancer associated fibroblasts in comparison to matched normal
lung fibroblasts (61), providing preliminary support that TBX4
expression may be involved in FP biology.
Through alignment of RNA sequence data generated in this
study to the ChHV5 genome we also were able to identify
evidence of the presence of the ChHV5 virus in 20/25 tumor
samples and 5/8 healthy tissue samples. The majority of samples
did not have large numbers of reads aligning to the ChHV5
genome, which may be a product of lowly expressed ChHV5
transcripts, or transcriptionally inactive virus, outcompeted
during transcriptome sequencing. A limitation of this study
was that a complementary ChHV5 qPCR-based assay was not
conducted on the samples studied to robustly identify the
presence or absence of ChHV5 virus DNA. Therefore, the data
generated in this study are insufficient to conclude that samples
without ChHV5 transcripts are free of ChHV5 infection. Given
the consistent detection of ChHV5 virus in FP tumors (25, 27, 62)
we expect that further qPCR-based analysis of these samples
would identify the presence of this virus in each tumor sample.
In comparison to previous work conducted by Duffy et al.
(35) we see a strong correlation with the gene expression
differences identified in the current study, despite geographical
andmethodological differences. Duffy et al. previously implicated
the Wnt signaling pathway as a potential therapeutic avenue for
FP and our current findings reiterate this potential. While we
did not replicate the finding of Duffy et al. of an upregulation
of WNT5A in FP tumors, among the top differentially expressed
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FIGURE 6 | An enrichment map of genes overlapping the top 20 most significant GO biological process ontology terms enriched among differentially expressed
genes in FP. The size of each node represents the number of genes differentially expressed in that ontology term, with thickness of edges between nodes representing
the number of genes overlapping. Node color represents the gene set enrichment analysis test statistic with Benjamini–Hochberg adjustment for multiple testing.
genes in this study several are involved in Wnt signaling
pathways. This includes upregulated genes CTHRC1,NLRC5 and
downregulated LGR5. CTHRC1 has been shown to selectively
activate the WNT/planar cell polarity pathway (63) and that
this may have a role in cervical cancer (64). NLRC5 has been
identified as a regulator of the Wnt/β-catenin signaling pathway
in clear cell renal carcinoma (65), and in the current study we
observe increased expression of NLRC5 in FP (log2FoldChange
= 3.39, padj = 3.71 × 10
−12). Upregulation of NLRC5 in FP
may represent a physiological anti-tumor response in sea turtles.
Studies have shown that NLRC5 is a transcriptional regulator
of MHC class I genes (66) and through this, activates cytotoxic
CD8+ T cells as part of an anti-tumor immune response (67). The
increased tumor expression of NLRC5 is associated with better
outcomes in human cancer (68) and is a target of interest in anti-
tumor immunity in transmissible tumors of another endangered
species; the Tasmanian devil (69). Furthermore, downregulation
of LGR5 in FP (log2FoldChange = −4.56, padj = 1.03 ×
10−9) may also demonstrate evidence of an anti-tumor response
through regulation of the Wnt/β-catenin signaling pathway, as
increased expression of LGR5 is associated with poor prognosis in
glioma (70), breast cancer (71) and oral squamous cell carcinoma
(72). The consistent identification of the alteration of genes
involved in Wnt signaling in FP indicates that further in-depth
exploration of this pathway in FP is warranted.
Moving beyond individual genes, we next took a systems
biology based approach drawing upon the human centered
knowledge bases of Gene Ontology (GO) and the Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways. We
annotated all differentially expressed genes where possible with
their closest orthologous human protein match to enable a
comprehensive analysis within the human centered knowledge
bases. The GO based enrichment analysis identified 465
nominally significant ontology terms within the gene set. These
were primarily immune system based, and among the top 20
terms when considering the genes overlapping between them
two functional modules emerged. One module involved the most
significantly enriched GO biological process (BP), GO:0009617,
response to bacterium (padj = 1.77 × 10
−13), while the other
module was comprised of immune related processes. Enrichment
of genes involved in biological responses to bacterial infection
is intuitive given that FP tumors, as an externally exposed
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FIGURE 7 | A dot plot of nominally significant KEGG pathways enriched
among differentially expressed genes in FP. The x-axis shows the ratio of
differentially expressed genes in each term relative to the total number of
genes in that term. Dot size shows the number of differentially expressed
genes in that term and color is the gene set enrichment analysis test statistic
with Benjamini–Hochberg adjustment for multiple testing.
and compromised tissue have potential to become infected
with environmental bacteria. This bacterial infection interplays
with tumor-based processes meaning that the enrichment of
immune related GO terms is likely driven by tumor biology
but also contributed to by bacterial infection. This is also
reflected in the KEGG pathway-based analysis where the GSEA
identified that the most significantly enriched pathway was
hsa04060, cytokine-cytokine receptor interaction (padj = 8.72
× 10−7). It is well-established in humans that cytokines have
a fundamental role in the tumor microenvironment as well
as inflammation and infection control (73). Here in FP, it
is likely that the contribution of cytokine pathways is again
an interplay between immune processes related to bacterial
infection, and those related to tumorgenicity. This is supported
by histopathological examination of the tumors in this study
showing various degrees of lymphocytic infiltration. Given these
findings, a fundamental question arises: why is this immune
response insufficient to result in tumor regression in individuals
that exhibit progressive disease?
In relation to this question, given that the differentially
expressed genes at both the gene level and the systems level
implicate significant involvement of the immune system in FP
tumors, we explored immune checkpoint molecules in this data
as a potential future therapeutic avenue for FP treatment. The
inhibition of immune checkpoint molecules as a therapeutic
approach for the treatment of cancer is a rapidly growing field
(74). We targeted a non-exhaustive set of 13 established and
emerging immune checkpoint molecules identified from the
literature for assessment in the current dataset. Gene expression
of three checkpoint molecules, BTLA, PD-L2, and LAG3 was
significantly upregulated in FP tumors. Each of these molecules
represents a potential drug target opportunity to explore in the
treatment of FP. Trialing an existing human based inhibitor that
is injectable directly into FP tumors may substantially improve
the burden of FP management in sea turtle rehabilitation but
would require significant investment and carefully designed
clinical trials to identify a chemotherapeutic regimen. Given the
recent increases in stranded sea turtles with FP requiring care in
some regions, a therapy that facilitates rapid rehabilitation and
return to the environment could be very beneficial.
Here we have described the transcriptomic profiling of FP
tumors in green turtles, building upon prior work from (35)
but also identifying novel insights into this disease. While
in comparison to human tumors much remains unknown
about the basic biology of sea turtle FP there is significant
opportunity to further apply alternative approaches previously
established in humans and model organisms to increase our
understanding of this disease. Research approaches involving
single cell sequencing, long read sequencing, metagenomics and
proteomics all stand to substantially benefit the FP knowledge
base. Investment in this area may even offer returns to
human oncology (75). Wildlife health problems, such as FP,




Sampling of green turtles was carried out under permit number
TE181762-4 from the U.S. Fish andWildlife Service and with the
ethical approval of the University of Texas Rio Grande Valley’s
Institutional Animal Care and Use Committee (IACUC). The
nine turtles involved in this study were undergoing rehabilitative
care at Sea Turtle Inc., South Padre Island. At the time of
collection, three turtles had external cutaneous FP tumors and
for each turtle tumor burden was quantified and scaled according
to the National Oceanic and Atmospheric Administration
(NOAA) Ordinal Scale for Grading Fibropapillomatosis by
Photographic Comparison as described in (37). From these
three turtles, external FP tumors were sampled after removal
during rehabilitative surgery using CO2 laser resection. From
all turtles a single healthy control skin sample was collected
using 3–6mm punch biopsies of the dorsal proximal hind
flipper. Tissue samples were collected into RNA-later (Qiagen)
and stored at −80◦C until processing. All turtles sampled
in this study were juvenile green turtles of unknown sex.
Table 1 summarizes the individual characteristics of turtles in
this study.
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FIGURE 8 | An enrichment map of genes overlapping nominally significant KEGG pathways enriched among differentially expressed genes in FP. The size of each
node represents the number of genes differentially expressed in that KEGG pathway, with thickness of edges between nodes representing the number of genes
overlapping. Node color represents the gene set enrichment analysis test statistic with Benjamini–Hochberg adjustment for multiple testing.
Histopathological Studies of Tissue
Samples
For each tumor sample collected, ∼50% of the sample was fixed
in a 10% formalin solution. Tissues were processed into paraffin
blocks, sectioned by 5µm, mounted onto glass slides and stained
with hematoxylin and eosin using routine methods. Diagnosis
of fibropapilloma was confirmed based on previously described
histopathological features (76).
RNA Extraction and RNA-Seq
Tumor and healthy tissue samples were homogenized using a
rotor-stator homogenizer and total RNA was extracted using
the Qiagen AllPrep DNA/RNA Mini kit, according to the
manufacturer’s instructions. RNA quality was assessed on a 2200
TapeStation System (Agilent Technologies) with sample RIN
values ranging from 6.4 to 9.6 (µ = 8.4). mRNA sequencing
libraries were generated from up to 250 ng of total RNA and were
prepared using a KAPA RNA HyperPrep kit (Roche Diagnostics)
with polyA selection and indexed using a KAPA Dual-Indexed
adapter kit (Roche Diagnostics), according to manufacturer’s
instructions. Prepared libraries were evaluated via the 2200
TapeStation System and were pooled for paired-end 100 bp
sequencing on a HiSeq 2500 system (Illumina).
Quality Control of RNA Sequence Data
Sequence data was demultiplexed using bcl2fastq. Raw
sequencing reads were processed with TrimGalore (version 0.6.5,
https://www.bioinformatics.babraham.ac.uk/projects/trim_
galore/), using Cutadapt (77) to remove adapter sequences and
indexes from reads and to exclude low quality sequences using
a Phred score of 30 and discarding reads with lengths shorter
than 25 bp, unpaired reads were not retained. FastQC (version
0.11.9, https://www.bioinformatics.babraham.ac.uk/projects/
fastqc/) was used to assess the data quality of the processed
reads. To avoid potential bias in analysis, two individual samples
were excluded due to overall differences in total sequencing
content, one tumor tissue (FP03-05, Beach Bum) had over 83
million more paired-end reads than the next highest sample
and one healthy tissue (FP08-01, Robocop) had over 2.5 million
less paired-end reads than the next lowest sample and had an
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FIGURE 9 | Significant upregulation of three immune checkpoint genes in FP. The x-axis in each plot panel separates the box plots of tissue samples into the healthy
control skin group and tumor group. The y-axis plots the log2-transformed normalized read count for each sample.
identified technical collection issue post sequencing, whereby
a less than optimal amount of tissue had been obtained in the
healthy tissue biopsy collection. In the remaining 33 samples, the
mean and median number of paired-end sequencing reads was
26,607,522 and 23,683,506 respectively, ranging from 4,447,485
to 70,675,924 reads.
Sequence Alignment and Quantification of
Turtle Gene Expression
The CheMyd_1.0 reference assembly for C. mydas was
obtained from NCBI [GenBank assembly accession number:
GCA_000344595.1] (78). Reads were aligned to the reference
assembly using HISAT2 (version 2.2.0) (79) with an overall
alignment per sample ranging from 75.26 to 88.29% (µ
= 84.19%). Transcript abundance was quantified in each
sample using htseq-count (version 0.11.2) (80) at the gene
level according to the defined genomic features of the
CheMyd_1.0 assembly.
Differential Expression Analysis
Differential expression analysis was conducted with DESeq2
(version 1.28.1) (81). Genes with low counts were filtered
from the analysis, retaining genes with more than five counts
in two or more samples. This corresponded to 17,698 genes
(83%). To calculate factors of unwanted variation in this sample
using RUVSeq (version 1.22.0) (82), a first pass differential
expression analysis was conducted to identify a set of in-
silico empirical negative control genes. This corresponded to
a model comparing 25 tumor samples to 8 healthy tissue
samples with inclusion of a turtle covariate in the model to
account for multiple tumor samples obtained from individual
sea turtles. Using a test statistic p-value of >0.5 to identify
genes not differentially expressed in the comparisons there
were 5,730 genes identified as empirical control genes from the
analysis. Using RUVSeq, two factors of unwanted variation were
calculated from the data. These factors were then incorporated
into the DESeq2 analysis design and an analysis was conducted
to identify differentially expressed genes with a log2 fold
change threshold of 1 and a false discovery rate threshold
of 0.05. Relative log expression plots of the data unadjusted
and after normalization, including the two factors of unwanted
variations from RUVSeq are shown in Supplementary Figures 1,
2, respectively. The differential expression analysis was visualized
as a volcano plot using the “EnhancedVolcano” package
(version 1.6.0) (83). Correlations of previously published
differential gene expression changes with the results from
this study were calculated using a Pearson correlation test
in R (version 4.0.0).
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Human Ortholog Identification
To enable pathway based and gene set enrichment analyses
in this data sea turtle genes were matched to their closest
matching human gene orthologs based on protein amino acid
sequence homology. To accurately draw upon human biological
understandings for inference in sea turtle fibropapilloma the
defined set of 28,672 proteins for the CheMyd_1.0 reference












LOC102933512 PDCD1LG2 PD-L2 3.27 0.45 0.0001
BTLA BTLA BTLA 3.59 0.57 0.0009
LAG3 LAG3 LAG-3 6.41 1.42 0.01
LOC102947343 CTLA4 CTLA-4 4.39 1.11 0.09
LOC114022564 CD276 B7-H3 1.99 0.36 0.19
LOC114021416 CD276 B7-H3 3.74 1.00 0.20
CD274 CD274 PD-L1 1.92 0.38 0.35
LOC102941709 HAVCR2 TIM-3 1.81 0.35 0.46
LOC114022559 CD276 B7-H3 3.14 1.10 0.83
LOC114018541 CD274 PD-L1 0.49 0.71 1
CD276 CD276 B7-H3 0.15 0.33 1
LOC102929593 CD276 B7-H3 0.48 0.28 1
LOC114018946 CTLA4 CTLA-4 2.05 0.87 1
HHLA2 HHLA2 B7-H7 0.09 0.50 1
PDCD1 PDCD1 PD-1 2.05 0.58 1
LOC114018671 TMIGD2 CD28H 1.16 0.43 1
VSIR VSIR VISTA 1.37 0.32 1
VTCN1 VTCN1 B7-H4 −0.75 0.61 1
was compared to the human landmark protein database using
NCBI’s protein BLAST (84–86) to identify the closest human
orthologous match. Initially the blastp query was run with
the following parameters: –max_target_seqs 1 –max_hsps 1 –
evalue 1e−6. This identified a match for 27,961 sea turtle
proteins (97.5%). For the remaining 711 sea turtle proteins,
the blastp analysis was repeated reducing the threshold of
the expect value (evalue) to 0.01. This matched a further
165 human proteins to turtle proteins. Finally, the evalue
threshold was reduced to 1, matching a further 182 proteins. In
total 28,308 protein sequences (98.7%) from the CheMyd_1.0
reference were successfully matched with a human landmark
database protein.
Turtle and human protein accession numbers were converted
to gene symbols using bioDBnet (87). A subset of 211 turtle
protein isoforms of 101 individual turtle genes matched to
multiple human genes. When there was concordance between
the human and turtle gene symbols for one or more of the
turtle protein isoforms, that gene symbol was used as the
match between turtle and human. For the remaining genes,
the gene symbol corresponding to the blastp result with the
lowest evalue was used. For evalue ties the gene symbol of
the result corresponding to the longest turtle protein isoform
was used.
For the remaining 364 turtle proteins that could not
be matched to a human protein, the sea turtle genome
gene annotation was used. For 2,233 turtle genes, including
predicted tRNA molecules and other non-coding genes, a
corresponding protein sequence was not available and for these
genes the sea turtle genome gene annotation was retained.
Supplementary Table 6 provides a mapping from CheMyd_1.0
gff_file gene identifiers through to the human based genematches
used in this project.
FIGURE 10 | Comparison of differentially expressed genes reported in Duffy et al. to the current study. (A) log2fold correlations between 449 overlapping transcripts
between the two studies. (B) log2fold correlations for the subset of overlapping transcripts that were differentially expressed in both studies.
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Gene Set Enrichment Analysis
Gene set enrichment analysis (GSEA) was conducted using
clusterProfiler (version 3.16.1) (88). Human gene symbols
from the orthologous matching analysis of sea turtle genes
were annotated with Gene Ontology (GO) terms and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathways. An
adjusted p-value of < 0.1 was used to identify input genes for
this analysis. For each duplicate ortholog the most significant
differentially expressed gene value was used in the GSEA
analyses. The background gene set used was all orthologous
human genes identified as matching a sea turtle gene. Test
statistics were adjusted for multiple testing using the Benjamini–
Hochberg method.
Detection of Chelonid Alphaherpesvirus 5
Sequences
The chelonid alphaherpesvirus 5 (ChHV5) reference assembly
was obtained from NCBI [GenBank assembly accession number:
GCA_008792165.1] (89). Reads were aligned to the reference
assembly using HISAT2 (version 2.2.0) (79) and transcript
abundance was quantified in each sample using htseq-count
(version 0.11.2) (80) at the gene level according to the defined
genomic features of the ChHV5 assembly. Differential gene
expression was not conducted for ChHV5 with results only
reported as a presence or absence of viral transcripts in
each sample.
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